RecruitingNCT06654895

Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study


Sponsor

Bluejay Diagnostics, Inc.

Enrollment

700 participants

Start Date

Nov 12, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.


Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a bedside device that continuously monitors IL-6 — a protein that spikes when the body is fighting a serious infection — can help doctors better track and manage sepsis (a life-threatening infection response) and septic shock in ICU patients. **You may be eligible if...** - You are 22 or older - You are an ICU patient who meets the clinical criteria for sepsis or septic shock (suspected or confirmed infection causing organ dysfunction, or requiring medications to maintain blood pressure) **You may NOT be eligible if...** - You are under 22 years old - You do not meet the diagnostic criteria for sepsis or septic shock - You are unable to provide consent (or a surrogate cannot) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

University of Florida College of Medicine

Gainesville, Florida, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Wake Forest School of Medicine

Winston-Salem, North Carolina, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Intermountain Health

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06654895